Skip to main content

Table 4 Characteristics and sonographic follow-up of RAS-positive benign nodules

From: The variable phenotype and low-risk nature of RAS-positive thyroid nodules

Subject number

Sex

Age at study entry (years)

RAS mutation

Nodule size (mm) and parenchyma at study entry

FNA cytology at study entry

Previous or subsequent ultrasound

Duration of sonographic follow-up

Previous FNA cytology

(date, size (mm), parenchyma)

(date, result)

9

Female

52

HRAS G12V

11/2010, 18 × 5 × 11, <25 % Cystic

Benign

02/2013, 16 × 11 × 9, Cystic (<25 %)

3.9 years (no growth)

Not performed

10/2014, 17 × 10 × 8, N/A

 

10

Female

52

HRAS Q61K

03/2012, 16 × 14 × 9, Solid

Benign

09/2008, 17 × 12 × 11, Solid

3.4 years (no growth)

11/2008, Benign cytology

11/2008, 17 × 10 × 10, N/A

 

01/2012, 16 × 15 × 9, Solid

11

Female

37

KRAS G12V

09/2011, 15 × 11 × 9, <25 % Cystic

Benign

-

N/A

Not performed

12

Female

54

KRAS G12V

10/2010, 14 × 14 × 8, Solid

Benign

07/1990, 13 × 12 × 7, N/A 10/1993, 14 × 12 × 8, N/A 05/1998, 15 × 13 × 8, Solid 06/1998, 15 × 13 × 8, Solid 10/1999, 15 × 13 × 7, Solid 07/2003, 15 × 14 × 7, Solid 07/2005, 14 × 14 × 8, Solid 10/2007, 15 × 14 × 7, Solid 01/2008, 13 × 12 × 7, Solid 08/2009, 14 × 13 × 8, Solid 09/2010, 16 × 15 × 9, Solid 07/2011, 16 × 13 × 7, Solid 01/2012, 15 × 15 × 7, Solid 01/2013, 16 × 15 × 8, Solid 07/2014, 15 × 14 × 9, Solid

24.0 years (no growth)

06/1998, Benign cytology

13

Female

54

NRAS Q61K

04/2011, 15 × 12 × 11, <25 % Cystic

Benign

05/2006, 15 × 9 × 9, Cystic (<25 %) 09/2006, 14 × 10 × 9, Cystic (<25 %) 06/2009, 12 × 11 × 11, Cystic (<25 %) 04/2011, 16 × 13 × 10, N/A 04/2012, 17 × 12 × 12, Cystic (<25 %) 06/2013, 15 × 12 × 10, Cystic (<25 %)

7.0 years (no growth)

09/2006, Benign cytology

14

Female

30

NRAS Q61R

09/2011, 16 × 14 × 9, Solid

Benign

08/2008, 13 × 13 × 8, Solid 12/2008, 13 × 13 × 9, Solid 07/2011, 15 × 14 × 8, N/A

3.1 years (no growth)

12/2008, Benign cytology

15

Female

62

NRAS Q61R

01/2012, 17 × 14 × 12, Solid

AUS + Afirma GEC ‘Benign’

N/A

N/A

04/2012, AUS

05/2012, Afirma GEC: ‘benign’

16

Female

64

HRAS G12V

11/2010, 23 × 19 × 15, <25 % Cystic

AUS

N/A

N/A

01/2011, Surgerya: benign histology

17

Male

46

HRAS Q61K

03/2012, 56 × 45 × 33, Solid

Follicular neoplasm

N/A

N/A

05/2012, Surgerya: benign histology

  1. aSurgery after study entry. AUS, atypia of undetermined significance; FNA, fine needle aspiration; GEC, gene expression classifier; N/A, not available